_id
6915ecdbbc934aba376b1da9
Ticker
RCKT
Name
Rocket Pharmaceuticals Inc
Exchange
NASDAQ
Address
9 Cedarbrook Drive, Cranbury, NJ, United States, 08512
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.rocketpharma.com
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States. It develops vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardiac disorder that is characterized by a progressive loss of cardiac muscle mass, severe right ventricular dilation, dysplasia, fibrofatty replacement of the myocardium and a high propensity to arrhythmias and sudden death (RP-A601), which is in phase 1; and BAG3 Dilated Cardiomyopathy (BAG3-DCM), which is a form of cardiomyopathy and is characterized by progressive thinning of the walls of the heart, which is in preclinical stage. It also develops vivo lentiviral (LV) programs, which include programs for Leukocyte Adhesion Deficiency-I (LAD-I), a genetic disorder that causes the immune system to malfunction (RP-L201); Fanconi Anemia (FA), a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells (RP-L102); and Pyruvate Kinase Deficiency (PKD), a red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia (RP-L301). It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; REGENXBIO, Inc.; and Temple University. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey.
Last Close
3.63
Volume
1332864
Current Price
3.45
Change
-4.958677685950406
Last Updated
2025-12-03T12:46:37.179Z
Image
data:image/webp;base64,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
Ipo Date
2015-02-18T00:00:00.000Z
Market Cap
334406656
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8690000000000001
Sentiment Sources
3
Rating
4.6111
Target Price
7.9546
Strong Buy
12
Buy
5
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
52247000
Operating Income
-52247000
Interest Expense
473000
Pretax Income
-50332000
Net Income
-50332000
Eps
-0.451120261068239
Dividends Per Share
-
Shares Outstanding
108222228
Income Tax Expense
-
EBITDA
-46619000
Operating Margin
-
Total Other Income Expense Net
1915000
Cash
75948000
Short Term Investments
146810000
Receivables
-
Inventories
-
Total Current Assets
227680000
Property Plant Equipment
74169000
Total Assets
368033000
Payables
-
Short Term Debt
2912000
Long Term Debt
-
Total Liabilities
54364000
Equity
313669000
Depreciation
3240000
Change In Working Capital
-11496000
Cash From Operations
-50428000
Capital Expenditures
54000
Cash From Investing
93616000
Cash From Financing
-59000
Net Change In Cash
43129000
PE
-
PB
1.2271548007613122
ROE
-16.04621432146626
ROA
-13.67594753731323
FCF
-50482000
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
52247000
Quarters > 0 > income Statement > operating Income
-52247000
Quarters > 0 > income Statement > interest Expense
473000
Quarters > 0 > income Statement > pretax Income
-50332000
Quarters > 0 > income Statement > net Income
-50332000
Quarters > 0 > income Statement > eps
-0.451120261068239
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
111571136
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-46619000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1915000
Quarters > 0 > balance Sheet > cash
75948000
Quarters > 0 > balance Sheet > short Term Investments
146810000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
227680000
Quarters > 0 > balance Sheet > property Plant Equipment
74169000
Quarters > 0 > balance Sheet > total Assets
368033000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
2912000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
54364000
Quarters > 0 > balance Sheet > equity
313669000
Quarters > 0 > cash Flow > net Income
-50332000
Quarters > 0 > cash Flow > depreciation
3240000
Quarters > 0 > cash Flow > change In Working Capital
-11496000
Quarters > 0 > cash Flow > cash From Operations
-50428000
Quarters > 0 > cash Flow > capital Expenditures
54000
Quarters > 0 > cash Flow > cash From Investing
93616000
Quarters > 0 > cash Flow > cash From Financing
-59000
Quarters > 0 > cash Flow > net Change In Cash
43129000
Quarters > 0 > ratios > PE
-0.451120261068239
Quarters > 0 > ratios > PB
1.2271548007613122
Quarters > 0 > ratios > ROE
-16.04621432146626
Quarters > 0 > ratios > ROA
-13.67594753731323
Quarters > 0 > ratios > FCF
-50482000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
2539000
Quarters > 1 > income Statement > gross Profit
-2539000
Quarters > 1 > income Statement > operating Expenses
71149000
Quarters > 1 > income Statement > operating Income
-71149000
Quarters > 1 > income Statement > interest Expense
473000
Quarters > 1 > income Statement > pretax Income
-68919000
Quarters > 1 > income Statement > net Income
-68919000
Quarters > 1 > income Statement > eps
-0.6207820134755068
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
111019647
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-65867000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2230000
Quarters > 1 > balance Sheet > cash
32819000
Quarters > 1 > balance Sheet > short Term Investments
238675000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
277155000
Quarters > 1 > balance Sheet > property Plant Equipment
77640000
Quarters > 1 > balance Sheet > total Assets
420979000
Quarters > 1 > balance Sheet > payables
1709000
Quarters > 1 > balance Sheet > short Term Debt
2894000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
66768000
Quarters > 1 > balance Sheet > equity
354211000
Quarters > 1 > cash Flow > net Income
-68919000
Quarters > 1 > cash Flow > depreciation
2579000
Quarters > 1 > cash Flow > change In Working Capital
8731000
Quarters > 1 > cash Flow > cash From Operations
-48964000
Quarters > 1 > cash Flow > capital Expenditures
50000
Quarters > 1 > cash Flow > cash From Investing
31761000
Quarters > 1 > cash Flow > cash From Financing
215000
Quarters > 1 > cash Flow > net Change In Cash
-16988000
Quarters > 1 > ratios > PE
-0.6207820134755068
Quarters > 1 > ratios > PB
1.0813266164800077
Quarters > 1 > ratios > ROE
-19.457046788496122
Quarters > 1 > ratios > ROA
-16.371125400554423
Quarters > 1 > ratios > FCF
-49014000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
2989000
Quarters > 2 > income Statement > gross Profit
-2989000
Quarters > 2 > income Statement > operating Expenses
64388000
Quarters > 2 > income Statement > operating Income
-64388000
Quarters > 2 > income Statement > interest Expense
472000
Quarters > 2 > income Statement > pretax Income
-61334000
Quarters > 2 > income Statement > net Income
-61334000
Quarters > 2 > income Statement > eps
-0.5571084734996204
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
110093461
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-57873000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
3054000
Quarters > 2 > balance Sheet > cash
49810000
Quarters > 2 > balance Sheet > short Term Investments
268354000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
324493000
Quarters > 2 > balance Sheet > property Plant Equipment
80393000
Quarters > 2 > balance Sheet > total Assets
471066000
Quarters > 2 > balance Sheet > payables
2945000
Quarters > 2 > balance Sheet > short Term Debt
2876000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
58928000
Quarters > 2 > balance Sheet > equity
412138000
Quarters > 2 > cash Flow > net Income
-61334000
Quarters > 2 > cash Flow > depreciation
2989000
Quarters > 2 > cash Flow > change In Working Capital
-5713000
Quarters > 2 > cash Flow > cash From Operations
-55802000
Quarters > 2 > cash Flow > capital Expenditures
364000
Quarters > 2 > cash Flow > cash From Investing
-58035000
Quarters > 2 > cash Flow > cash From Financing
12000
Quarters > 2 > cash Flow > net Change In Cash
-113825000
Quarters > 2 > ratios > PE
-0.5571084734996204
Quarters > 2 > ratios > PB
0.9215904392460778
Quarters > 2 > ratios > ROE
-14.881908486963106
Quarters > 2 > ratios > ROA
-13.020256184908272
Quarters > 2 > ratios > FCF
-56166000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
9186000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
4593000
Quarters > 3 > income Statement > operating Expenses
62694000
Quarters > 3 > income Statement > operating Income
-62694000
Quarters > 3 > income Statement > interest Expense
473000
Quarters > 3 > income Statement > pretax Income
-60327000
Quarters > 3 > income Statement > net Income
-60327000
Quarters > 3 > income Statement > eps
-0.6185479360859842
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
97530032
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-57493000
Quarters > 3 > income Statement > operating Margin
-682.495101241019
Quarters > 3 > income Statement > total Other Income Expense Net
2367000
Quarters > 3 > balance Sheet > cash
163635000
Quarters > 3 > balance Sheet > short Term Investments
208701000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
378183000
Quarters > 3 > balance Sheet > property Plant Equipment
83322000
Quarters > 3 > balance Sheet > total Assets
527700000
Quarters > 3 > balance Sheet > payables
1625000
Quarters > 3 > balance Sheet > short Term Debt
2857000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
64466000
Quarters > 3 > balance Sheet > equity
463234000
Quarters > 3 > cash Flow > net Income
-60327000
Quarters > 3 > cash Flow > depreciation
2361000
Quarters > 3 > cash Flow > change In Working Capital
-732000
Quarters > 3 > cash Flow > cash From Operations
-46957000
Quarters > 3 > cash Flow > capital Expenditures
309000
Quarters > 3 > cash Flow > cash From Investing
-37871000
Quarters > 3 > cash Flow > cash From Financing
182864000
Quarters > 3 > cash Flow > net Change In Cash
98036000
Quarters > 3 > ratios > PE
-0.6185479360859842
Quarters > 3 > ratios > PB
0.7263685532581806
Quarters > 3 > ratios > ROE
-13.023007810307533
Quarters > 3 > ratios > ROA
-11.432063672541217
Quarters > 3 > ratios > FCF
-47266000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-5.145438711082082
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
9375000
Annuals > 0 > income Statement > gross Profit
-9375000
Annuals > 0 > income Statement > operating Expenses
273205000
Annuals > 0 > income Statement > operating Income
-273205000
Annuals > 0 > income Statement > interest Expense
1886000
Annuals > 0 > income Statement > pretax Income
-258746000
Annuals > 0 > income Statement > net Income
-258746000
Annuals > 0 > income Statement > eps
-2.7291644114454625
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
94807773
Annuals > 0 > income Statement > income Tax Expense
-1
Annuals > 0 > income Statement > EBITDA
-247485000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
14459000
Annuals > 0 > balance Sheet > cash
163635000
Annuals > 0 > balance Sheet > short Term Investments
208701000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
378183000
Annuals > 0 > balance Sheet > property Plant Equipment
83322000
Annuals > 0 > balance Sheet > total Assets
527700000
Annuals > 0 > balance Sheet > payables
1625000
Annuals > 0 > balance Sheet > short Term Debt
2857000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
64466000
Annuals > 0 > balance Sheet > equity
463234000
Annuals > 0 > cash Flow > net Income
-258746000
Annuals > 0 > cash Flow > depreciation
9375000
Annuals > 0 > cash Flow > change In Working Capital
1919000
Annuals > 0 > cash Flow > cash From Operations
-209724000
Annuals > 0 > cash Flow > capital Expenditures
5862000
Annuals > 0 > cash Flow > cash From Investing
131706000
Annuals > 0 > cash Flow > cash From Financing
185739000
Annuals > 0 > cash Flow > net Change In Cash
107721000
Annuals > 0 > ratios > PE
-2.7291644114454625
Annuals > 0 > ratios > PB
0.6324147592145654
Annuals > 0 > ratios > ROE
-55.85643540845447
Annuals > 0 > ratios > ROA
-49.03278377866212
Annuals > 0 > ratios > FCF
-215586000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
7098000
Annuals > 1 > income Statement > gross Profit
-7098000
Annuals > 1 > income Statement > operating Expenses
259659000
Annuals > 1 > income Statement > operating Income
-259659000
Annuals > 1 > income Statement > interest Expense
1875000
Annuals > 1 > income Statement > pretax Income
-245595000
Annuals > 1 > income Statement > net Income
-245595000
Annuals > 1 > income Statement > eps
-2.923436635434935
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
84009004
Annuals > 1 > income Statement > income Tax Expense
-245595000
Annuals > 1 > income Statement > EBITDA
-236622000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
14064000
Annuals > 1 > balance Sheet > cash
55904000
Annuals > 1 > balance Sheet > short Term Investments
317271000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
378222000
Annuals > 1 > balance Sheet > property Plant Equipment
87590000
Annuals > 1 > balance Sheet > total Assets
566341000
Annuals > 1 > balance Sheet > payables
1772
Annuals > 1 > balance Sheet > short Term Debt
2716000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
73767000
Annuals > 1 > balance Sheet > equity
492574000
Annuals > 1 > cash Flow > net Income
-245595000
Annuals > 1 > cash Flow > depreciation
7098000
Annuals > 1 > cash Flow > change In Working Capital
13458000
Annuals > 1 > cash Flow > cash From Operations
-194916000
Annuals > 1 > cash Flow > capital Expenditures
16472000
Annuals > 1 > cash Flow > cash From Investing
-98066000
Annuals > 1 > cash Flow > cash From Financing
208401000
Annuals > 1 > cash Flow > net Change In Cash
-84581000
Annuals > 1 > ratios > PE
-2.923436635434935
Annuals > 1 > ratios > PB
0.5270026886518574
Annuals > 1 > ratios > ROE
-49.85951349441911
Annuals > 1 > ratios > ROA
-43.36521636258014
Annuals > 1 > ratios > FCF
-211388000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
6266000
Annuals > 2 > income Statement > gross Profit
-6266000
Annuals > 2 > income Statement > operating Expenses
224343000
Annuals > 2 > income Statement > operating Income
-224343000
Annuals > 2 > income Statement > interest Expense
1909000
Annuals > 2 > income Statement > pretax Income
-221863000
Annuals > 2 > income Statement > net Income
-221863000
Annuals > 2 > income Statement > eps
-3.2555612579362037
Annuals > 2 > income Statement > dividends Per Share
172000
Annuals > 2 > income Statement > shares Outstanding
68148925
Annuals > 2 > income Statement > income Tax Expense
-2480000
Annuals > 2 > income Statement > EBITDA
-213688000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2480000
Annuals > 2 > balance Sheet > cash
140517000
Annuals > 2 > balance Sheet > short Term Investments
215877000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
364060000
Annuals > 2 > balance Sheet > property Plant Equipment
77645000
Annuals > 2 > balance Sheet > total Assets
551807000
Annuals > 2 > balance Sheet > payables
36660000
Annuals > 2 > balance Sheet > short Term Debt
2509000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
62121000
Annuals > 2 > balance Sheet > equity
489686000
Annuals > 2 > cash Flow > net Income
-221863000
Annuals > 2 > cash Flow > depreciation
6266000
Annuals > 2 > cash Flow > change In Working Capital
6076000
Annuals > 2 > cash Flow > cash From Operations
-178142000
Annuals > 2 > cash Flow > capital Expenditures
8619000
Annuals > 2 > cash Flow > cash From Investing
-69326000
Annuals > 2 > cash Flow > cash From Financing
155288000
Annuals > 2 > cash Flow > net Change In Cash
-92180000
Annuals > 2 > ratios > PE
-3.2555612579362037
Annuals > 2 > ratios > PB
0.43003103672557513
Annuals > 2 > ratios > ROE
-45.30719685676127
Annuals > 2 > ratios > ROA
-40.20663021672433
Annuals > 2 > ratios > FCF
-186761000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
5373000
Annuals > 3 > income Statement > gross Profit
-5373000
Annuals > 3 > income Statement > operating Expenses
167248000
Annuals > 3 > income Statement > operating Income
-167248000
Annuals > 3 > income Statement > interest Expense
5889000
Annuals > 3 > income Statement > pretax Income
-169069000
Annuals > 3 > income Statement > net Income
-169069000
Annuals > 3 > income Statement > eps
-2.6736441067511265
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
63235417
Annuals > 3 > income Statement > income Tax Expense
516000
Annuals > 3 > income Statement > EBITDA
-157807000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1821000
Annuals > 3 > balance Sheet > cash
232694000
Annuals > 3 > balance Sheet > short Term Investments
156046000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
392059000
Annuals > 3 > balance Sheet > property Plant Equipment
72348000
Annuals > 3 > balance Sheet > total Assets
497020000
Annuals > 3 > balance Sheet > payables
482
Annuals > 3 > balance Sheet > short Term Debt
2552000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
42296000
Annuals > 3 > balance Sheet > equity
454724000
Annuals > 3 > cash Flow > net Income
-169069000
Annuals > 3 > cash Flow > depreciation
5373000
Annuals > 3 > cash Flow > change In Working Capital
-3386000
Annuals > 3 > cash Flow > cash From Operations
-121163000
Annuals > 3 > cash Flow > capital Expenditures
7715000
Annuals > 3 > cash Flow > cash From Investing
18853000
Annuals > 3 > cash Flow > cash From Financing
37681000
Annuals > 3 > cash Flow > net Change In Cash
-64629000
Annuals > 3 > ratios > PE
-2.6736441067511265
Annuals > 3 > ratios > PB
0.42970557641558393
Annuals > 3 > ratios > ROE
-37.1805754699554
Annuals > 3 > ratios > ROA
-34.01653856987647
Annuals > 3 > ratios > FCF
-128878000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.451120261068239
Valuation > metrics > PB
1.2271548007613122
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-16.04621432146626
Profitability > metrics > ROA
-22.10646521433591
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.17331645779468166
Risk > metrics > Interest Coverage
-110.45877378435517
Risk > final Score
-382
Risk > verdict
High
Liquidity > metrics > Current Ratio
78.18681318681318
Liquidity > metrics > Quick Ratio
78.18681318681318
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-542
Prev Risks > 1
-486
Prev Risks > 2
-470
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T00:59:01.000Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-02
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.4247
Earnings History > 0 > eps Difference
0.4247
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.45
Earnings History > 1 > eps Estimate
-0.49
Earnings History > 1 > eps Difference
0.04
Earnings History > 1 > surprise Percent
8.1633
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.62
Earnings History > 2 > eps Estimate
-0.5622
Earnings History > 2 > eps Difference
-0.0578
Earnings History > 2 > surprise Percent
-10.281
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-05
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.56
Earnings History > 3 > eps Estimate
-0.5831
Earnings History > 3 > eps Difference
0.0231
Earnings History > 3 > surprise Percent
3.9616
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-24
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.62
Earnings History > 4 > eps Estimate
-0.7179
Earnings History > 4 > eps Difference
0.0979
Earnings History > 4 > surprise Percent
13.637
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-04
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.71
Earnings History > 5 > eps Estimate
-0.76
Earnings History > 5 > eps Difference
0.05
Earnings History > 5 > surprise Percent
6.5789
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-05
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.74
Earnings History > 6 > eps Estimate
-0.72
Earnings History > 6 > eps Difference
-0.02
Earnings History > 6 > surprise Percent
-2.7778
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-06
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.66
Earnings History > 7 > eps Estimate
-0.68
Earnings History > 7 > eps Difference
0.02
Earnings History > 7 > surprise Percent
2.9412
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-26
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.64
Earnings History > 8 > eps Estimate
-0.79
Earnings History > 8 > eps Difference
0.15
Earnings History > 8 > surprise Percent
18.9873
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-06
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.75
Earnings History > 9 > eps Estimate
-0.81
Earnings History > 9 > eps Difference
0.06
Earnings History > 9 > surprise Percent
7.4074
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.82
Earnings History > 10 > eps Estimate
-0.79
Earnings History > 10 > eps Difference
-0.03
Earnings History > 10 > surprise Percent
-3.7975
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-04
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.73
Earnings History > 11 > eps Estimate
-0.85
Earnings History > 11 > eps Difference
0.12
Earnings History > 11 > surprise Percent
14.1176
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-27
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.92
Earnings History > 12 > eps Estimate
-0.8
Earnings History > 12 > eps Difference
-0.12
Earnings History > 12 > surprise Percent
-15
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-03
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.87
Earnings History > 13 > eps Estimate
-0.79
Earnings History > 13 > eps Difference
-0.08
Earnings History > 13 > surprise Percent
-10.1266
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-08
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.83
Earnings History > 14 > eps Estimate
-0.68
Earnings History > 14 > eps Difference
-0.15
Earnings History > 14 > surprise Percent
-22.0588
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-05
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.67
Earnings History > 15 > eps Estimate
-0.71
Earnings History > 15 > eps Difference
0.04
Earnings History > 15 > surprise Percent
5.6338
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-24
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.69
Earnings History > 16 > eps Estimate
-0.76
Earnings History > 16 > eps Difference
0.07
Earnings History > 16 > surprise Percent
9.2105
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-03
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.79
Earnings History > 17 > eps Estimate
-0.61
Earnings History > 17 > eps Difference
-0.18
Earnings History > 17 > surprise Percent
-29.5082
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-09
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.55
Earnings History > 18 > eps Estimate
-0.65
Earnings History > 18 > eps Difference
0.1
Earnings History > 18 > surprise Percent
15.3846
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-10
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.65
Earnings History > 19 > eps Estimate
-0.69
Earnings History > 19 > eps Difference
0.04
Earnings History > 19 > surprise Percent
5.7971
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-25
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.08
Earnings History > 20 > eps Estimate
-0.51
Earnings History > 20 > eps Difference
-0.57
Earnings History > 20 > surprise Percent
-111.7647
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-04
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.53
Earnings History > 21 > eps Estimate
-0.46
Earnings History > 21 > eps Difference
-0.07
Earnings History > 21 > surprise Percent
-15.2174
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-05
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.45
Earnings History > 22 > eps Estimate
-0.51
Earnings History > 22 > eps Difference
0.06
Earnings History > 22 > surprise Percent
11.7647
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-06
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.45
Earnings History > 23 > eps Estimate
-0.49
Earnings History > 23 > eps Difference
0.04
Earnings History > 23 > surprise Percent
8.1633
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-05
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.39
Earnings History > 24 > eps Estimate
-0.49
Earnings History > 24 > eps Difference
0.1
Earnings History > 24 > surprise Percent
20.4082
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-07
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.38
Earnings History > 25 > eps Estimate
-0.49
Earnings History > 25 > eps Difference
0.11
Earnings History > 25 > surprise Percent
22.449
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-07
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.38
Earnings History > 26 > eps Estimate
-0.49
Earnings History > 26 > eps Difference
0.11
Earnings History > 26 > surprise Percent
22.449
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-08
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.43
Earnings History > 27 > eps Estimate
-0.62
Earnings History > 27 > eps Difference
0.19
Earnings History > 27 > surprise Percent
30.6452
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-07
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.66
Earnings History > 28 > eps Estimate
-0.45
Earnings History > 28 > eps Difference
-0.21
Earnings History > 28 > surprise Percent
-46.6667
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-07
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.4
Earnings History > 29 > eps Estimate
-0.43
Earnings History > 29 > eps Difference
0.03
Earnings History > 29 > surprise Percent
6.9767
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-08
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.4
Earnings History > 30 > eps Estimate
-0.36
Earnings History > 30 > eps Difference
-0.04
Earnings History > 30 > surprise Percent
-11.1111
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-05-11
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.42
Earnings History > 31 > eps Estimate
-0.33
Earnings History > 31 > eps Difference
-0.09
Earnings History > 31 > surprise Percent
-27.2727
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-07
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.72
Earnings History > 32 > eps Estimate
-0.31
Earnings History > 32 > eps Difference
-0.41
Earnings History > 32 > surprise Percent
-132.2581
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-11-08
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.27
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-08-03
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.96
Earnings History > 34 > eps Estimate
-1.88
Earnings History > 34 > eps Difference
0.92
Earnings History > 34 > surprise Percent
48.9362
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-05-10
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
BeforeMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-1.6
Earnings History > 35 > eps Estimate
-1.57
Earnings History > 35 > eps Difference
-0.03
Earnings History > 35 > surprise Percent
-1.9108
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-16
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
BeforeMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-1.92
Earnings History > 36 > eps Estimate
-1.73
Earnings History > 36 > eps Difference
-0.19
Earnings History > 36 > surprise Percent
-10.9827
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-11-09
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
BeforeMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-1.64
Earnings History > 37 > eps Estimate
-1.78
Earnings History > 37 > eps Difference
0.14
Earnings History > 37 > surprise Percent
7.8652
Earnings History > 38 > period
2016-06-30
Earnings History > 38 > report Date
2016-08-10
Earnings History > 38 > date
2016-06-30
Earnings History > 38 > before After Market
BeforeMarket
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-1.32
Earnings History > 38 > eps Estimate
-1.58
Earnings History > 38 > eps Difference
0.26
Earnings History > 38 > surprise Percent
16.4557
Earnings History > 39 > period
2016-03-31
Earnings History > 39 > report Date
2016-05-11
Earnings History > 39 > date
2016-03-31
Earnings History > 39 > before After Market
BeforeMarket
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-1.52
Earnings History > 39 > eps Estimate
-0.88
Earnings History > 39 > eps Difference
-0.64
Earnings History > 39 > surprise Percent
-72.7273
Earnings History > 40 > period
2015-12-31
Earnings History > 40 > report Date
2016-03-23
Earnings History > 40 > date
2015-12-31
Earnings History > 40 > before After Market
BeforeMarket
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-0.52
Earnings History > 40 > eps Estimate
-1.48
Earnings History > 40 > eps Difference
0.96
Earnings History > 40 > surprise Percent
64.8649
Earnings History > 41 > period
2015-09-30
Earnings History > 41 > report Date
2015-11-12
Earnings History > 41 > date
2015-09-30
Earnings History > 41 > before After Market
BeforeMarket
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-1
Earnings History > 41 > eps Estimate
-1.84
Earnings History > 41 > eps Difference
0.84
Earnings History > 41 > surprise Percent
45.6522
Earnings History > 42 > period
2015-06-30
Earnings History > 42 > report Date
2015-08-06
Earnings History > 42 > date
2015-06-30
Earnings History > 42 > before After Market
AfterMarket
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-0.12
Earnings History > 42 > eps Estimate
-0.98
Earnings History > 42 > eps Difference
0.86
Earnings History > 42 > surprise Percent
87.7551
Earnings History > 43 > period
2015-03-31
Earnings History > 43 > report Date
2015-05-15
Earnings History > 43 > date
2015-03-31
Earnings History > 43 > before After Market
BeforeMarket
Earnings History > 43 > currency
USD
Earnings History > 43 > eps Actual
-1.92
Earnings History > 43 > eps Estimate
-1.58
Earnings History > 43 > eps Difference
-0.34
Earnings History > 43 > surprise Percent
-21.519
Earnings History > 44 > period
2014-12-31
Earnings History > 44 > report Date
2015-03-31
Earnings History > 44 > date
2014-12-31
Earnings History > 44 > before After Market
BeforeMarket
Earnings History > 44 > currency
USD
Earnings History > 44 > eps Actual
-12.88
Earnings History > 44 > eps Estimate
-1.76
Earnings History > 44 > eps Difference
-11.12
Earnings History > 44 > surprise Percent
-631.8182
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States. It develops vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardiac disorder that is characterized by a progressive loss of cardiac muscle mass, severe right ventricular dilation, dysplasia, fibrofatty replacement of the myocardium and a high propensity to arrhythmias and sudden death (RP-A601), which is in phase 1; and BAG3 Dilated Cardiomyopathy (BAG3-DCM), which is a form of cardiomyopathy and is characterized by progressive thinning of the walls of the heart, which is in preclinical stage. It also develops vivo lentiviral (LV) programs, which include programs for Leukocyte Adhesion Deficiency-I (LAD-I), a genetic disorder that causes the immune system to malfunction (RP-L201); Fanconi Anemia (FA), a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells (RP-L102); and Pyruvate Kinase Deficiency (PKD), a red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia (RP-L301). It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; REGENXBIO, Inc.; and Temple University. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWe're Keeping An Eye On Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Rate - simplywall.st
12/9/2025
We're Keeping An Eye On Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Rate simplywall.st
Read more →Breakout Move: Will Aeva Technologies Inc stock remain a Wall Street favorite - moha.gov.vn
12/8/2025
Breakout Move: Will Aeva Technologies Inc stock remain a Wall Street favorite moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$7.9546
Analyst Picks
Strong Buy
12
Buy
5
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 80.80% of the total shares of Rocket Pharmaceuticals Inc
1.
RTW INVESTMENTS, LLC(16.3922%)
since
2025/06/30
2.
Maverick Capital Ltd(7.7512%)
since
2025/06/30
3.
BlackRock Inc(6.8845%)
since
2025/06/30
4.
Vanguard Group Inc(5.674%)
since
2025/06/30
5.
Suvretta Capital Management, LLC(3.8398%)
since
2025/06/30
6.
MPM Oncology Impact Management LP(3.6172%)
since
2025/06/30
7.
Morgan Stanley - Brokerage Accounts(2.9369%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(2.5101%)
since
2025/07/31
9.
RTW Biotech Opportunities Ord(2.2249%)
since
2024/12/31
10.
Millennium Management LLC(2.1768%)
since
2025/06/30
11.
Geode Capital Management, LLC(1.8821%)
since
2025/06/30
12.
iShares Russell 2000 ETF(1.8684%)
since
2025/08/31
13.
Newtyn Management LLC(1.8535%)
since
2025/06/30
14.
State Street Corp(1.8013%)
since
2025/06/30
15.
Two Sigma Investments LLC(1.599%)
since
2025/06/30
16.
Prosight Management, LP(1.4648%)
since
2025/06/30
17.
Goldman Sachs Group Inc(1.4601%)
since
2025/06/30
18.
Qube Research & Technologies(1.4349%)
since
2025/06/30
19.
Two Sigma Advisers, LLC(1.3811%)
since
2025/06/30
20.
JPMorgan Chase & Co(1.1193%)
since
2025/06/30
21.
The Toronto-Dominion Bank(1.0194%)
since
2025/06/30
22.
T. Rowe Price Associates, Inc.(1.0193%)
since
2025/06/30
23.
D. E. Shaw & Co LP(0.9201%)
since
2025/06/30
24.
Vanguard Institutional Extnd Mkt Idx Tr(0.858%)
since
2025/07/31
25.
Fidelity Small Cap Index(0.7842%)
since
2025/06/30
26.
Vanguard Explorer Inv(0.6474%)
since
2025/06/30
27.
T. Rowe Price Health Sciences(0.6308%)
since
2025/07/31
28.
HBM Healthcare Investments AG Ord(0.6268%)
since
2025/06/30
29.
iShares Russell 2000 Value ETF(0.5714%)
since
2025/08/31
30.
iShares Biotechnology ETF(0.5461%)
since
2025/08/31
31.
Fidelity Extended Market Index(0.4331%)
since
2025/07/31
32.
Nordea 2 - BetaPlus Enh GlSCap Eq BI USD(0.3838%)
since
2025/07/31
33.
Schwab US Small-Cap ETF™(0.3731%)
since
2025/08/30
34.
Vanguard Russell 2000 ETF(0.3727%)
since
2025/07/31
35.
JPM Thematics Genetic Thrps C2 dist USD(0.3703%)
since
2025/07/31
36.
Federated Hermes MDT Small Cap Core IS(0.3088%)
since
2025/06/30
37.
Federated Hermes MDT SCC Institutional(0.3088%)
since
2025/06/30
38.
State St Russell Sm Cap® Indx SL Cl I(0.2612%)
since
2025/08/31
39.
Federated Hermes MDT SCG Institutional(0.246%)
since
2025/06/30
40.
Federated Hermes MDT Small Cap Growth IS(0.246%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.4247
Date
2025-09-30
EPS Actual
-0.45
EPS Estimate
-0.49
EPS Difference
0.04
Surprise Percent
8.1633%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.